Advertisement

Journal of Neurology

, Volume 257, Issue 11, pp 1890–1898 | Cite as

Huntington’s disease: changes in saccades and hand-tapping over 3 years

  • Chrystalina A. AntoniadesEmail author
  • Zheyu Xu
  • Sarah L. Mason
  • R. H. S. Carpenter
  • Roger A. Barker
Original Communication

Abstract

Saccades and hand-tapping are both potential biomarkers in patients with Huntington’s disease (HD). While it is well known that patients with manifest Huntington’s disease display abnormalities in both of these tasks, less is known about how these abnormalities progress over time, or to what extent premanifest patients are affected. This study was designed to address these issues. We examined premanifest and manifest Huntington’s cohorts, together with a group of controls, over a 3-year period. Data were collected using a portable head-mounted saccadometer and a computerised hand-tapping device. Both premanifest and manifest Huntington’s disease patients display significant and systematic changes from year to year in the parameters describing saccadic latency, while controls remain unchanged. By contrast, although hand-tapping was abnormal in HD patients, annual changes were much smaller. Measuring the rate of progression of saccadic abnormalities in manifest HD patients may provide a way to track disease progression, and thus help to evaluate novel therapies to modify the disease. The clear-cut progression in saccadic abnormalities in the premanifest group may prove useful in the future as a predictor of time to disease onset.

Keywords

Saccadic eye movements Hand-tapping Biomarkers Huntington’s disease 

Notes

Acknowledgments

The authors thank all the patients who have participated in this study at the Cambridge Centre for Brain Repair. Many thanks to James FitzGerald for comments on the manuscript. This work has been supported by an award to C.A.A by the Medical Research Council of the United Kingdom and through the NIHR Biomedical Research Centre award to the Department of Clinical Neurosciences, Addenbrooke’s Hospital, Cambridge, United Kingdom.

References

  1. 1.
    Ali FR, Michell AW, Barker RA, Carpenter RH (2006) The use of quantitative oculometry in the assessment of Huntington’s disease. Exp Brain Res Exp Hirnforsch 169:237–245CrossRefGoogle Scholar
  2. 2.
    Antoniades CA, Altham PM, Mason SL, Barker RA, Carpenter R (2007) Saccadometry: a new tool for evaluating presymptomatic Huntington patients. Neuroreport 18:1133–1136CrossRefPubMedGoogle Scholar
  3. 3.
    Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS (2009) Motor abnormalities in premanifest persons with Huntington’s disease: the PREDICT-HD study. Mov Disord 24:1763–1772CrossRefPubMedGoogle Scholar
  4. 4.
    Blekher TJS, Marshall J, White K, Hui S, Weaver M, Gray J, Yee R, Stout JC, Beristain X, Wojcieszek J, Foroud T (2006) Saccades in presymptomatic and early stages of Huntington disease. Neurology 67:394–399CrossRefPubMedGoogle Scholar
  5. 5.
    Blekher T, Weaver MR, Cai X, Hui S, Marshall J, Jackson JG, Wojcieszek J, Yee RD, Foroud TM (2009) Test-retest reliability of saccadic measures in subjects at risk for Huntington disease. Invest Ophthalmol Vis Sci 50:5707–5711CrossRefPubMedGoogle Scholar
  6. 6.
    Blekher TMYR, Kirkwood SC, Hake AM, Stout JC, Weaver MR, Foroud TM (2004) oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington’s disease. In: Vision research, pp 2729–2736Google Scholar
  7. 7.
    Carpenter RH, Williams ML (1995) Neural computation of log likelihood in control of saccadic eye movements. Nature 377:59–62CrossRefPubMedGoogle Scholar
  8. 8.
    Carpenter RHS (1994) SPIC: a PC-based system for rapid measurement of saccadic responses. J Physiol 4P:480Google Scholar
  9. 9.
    Garcia Ruiz PJ, Hernandez J, Cantarero S, Bartolome M, Sanchez Bernardos V, Garcia de Yebenez J (2002) Bradykinesia in Huntington’s disease. A prospective, follow-up study. J Neurol 249:437–440CrossRefPubMedGoogle Scholar
  10. 10.
    Golding CVP, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C (2006) Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology 67:485–487CrossRefPubMedGoogle Scholar
  11. 11.
    Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C (2008) Oculomotor deficits indicate the progression of Huntington’s disease. Prog Brain Res 171:555–558CrossRefPubMedGoogle Scholar
  12. 12.
    Hikosaka O, Takikawa Y, Kawagoe R (2000) Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 80:953–978PubMedGoogle Scholar
  13. 13.
    Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ane MN, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T (2003) Profile of cognitive progression in early Huntington’s disease. Neurology 61:1702–1706PubMedGoogle Scholar
  14. 14.
    Isoda M, Hikosaka O (2008) Role for subthalamic nucleus neurons in switching from automatic to controlled eye movement. J Neurosci 28:7209–7218CrossRefPubMedGoogle Scholar
  15. 15.
    Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T (2000) Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol 57:1040–1044CrossRefPubMedGoogle Scholar
  16. 16.
    Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T (2000) Subtle changes among presymptomatic carriers of the Huntington’s disease gene. J Neurol Neurosurg Psychiatry 69:773–779CrossRefPubMedGoogle Scholar
  17. 17.
    Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, Foroud T (1999) Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 56:563–568CrossRefPubMedGoogle Scholar
  18. 18.
    Klein C, Foerster F, Hartnegg K, Fischer B (2005) Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. Brain Res Dev Brain Res 160:113–123CrossRefPubMedGoogle Scholar
  19. 19.
    Kolmogorov A (1941) Confidence limits for an unknown distribution function. Ann Math Stat 23:525–540Google Scholar
  20. 20.
    Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR (2004) A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clin Genet 65:267–277CrossRefPubMedGoogle Scholar
  21. 21.
    Lasker AG, Zee DS (1997) Ocular motor abnormalities in Huntington’s disease. Vis Res 37:3639–3645CrossRefPubMedGoogle Scholar
  22. 22.
    Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1987) Saccades in Huntington’s disease: initiation defects and distractibility. Neurology 37:364–370PubMedGoogle Scholar
  23. 23.
    Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1988) Saccades in Huntington’s disease: slowing and dysmetria. Neurology 38:427–431PubMedGoogle Scholar
  24. 24.
    Lasker G, Adrian ZD (1997) Ocular motor abnormalities in Huntington’s disease. Vis Res 37:3639–3645CrossRefPubMedGoogle Scholar
  25. 25.
    Leigh RJKC (2004) Using saccades as a research tool in the clinical neurosciences. Brain 127:460–477CrossRefPubMedGoogle Scholar
  26. 26.
    Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA (1983) Abnormal ocular motor control in Huntington’s disease. Neurology 33:1268–1275PubMedGoogle Scholar
  27. 27.
    Leigh RJZD (2006) The neurology of eye movementsGoogle Scholar
  28. 28.
    Michell AW, Goodman AO, Silva AH, Lazic SE, Morton AJ, Barker RA (2008) Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington’s disease. J NeurolGoogle Scholar
  29. 29.
    Ober JK, Przedpelska-Ober E, Gryncewicz W, Dylak J, Carpenter RS, Ober JJ (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Modelling and measurement in medicineGoogle Scholar
  30. 30.
    Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, McDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M (2007) Detection of Huntington’s disease decades before diagnosis: the predict HD study. J Neurol Neurosurg PsychiatryGoogle Scholar
  31. 31.
    Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J (2005) Executive dysfunction in early stages of Huntington’s disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 239:11–19CrossRefPubMedGoogle Scholar
  32. 32.
    Peltsch A, Hoffman A, Armstrong I, Pari G, Munoz DP (2008) Saccadic impairments in Huntington’s disease. Exp Brain Res Exp Hirnforsch 186:457–469CrossRefGoogle Scholar
  33. 33.
    Rupp J, Blekher T, Jackson J, Beristain X, Marshall J, Hui S, Wojcieszek J, Foroud T (2010) Progression in prediagnostic Huntington disease. J Neurol Neurosurg Psychiatry 81:379–384CrossRefPubMedGoogle Scholar
  34. 34.
    Rupp J, Blekher T, Jackson J, Beristain X, Marshall J, Hui S, Wojcieszek J, Foroud T (2009) Progression in prediagnostic huntington disease. J Neurol Neurosurg PsychiatryGoogle Scholar
  35. 35.
    Saft C, Andrich J, Meisel NM, Przuntek H, Muller T (2006) Assessment of simple movements reflects impairment in Huntington’s disease. Mov Disord 21:1208–1212CrossRefPubMedGoogle Scholar
  36. 36.
    Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor, executive, and memory function in preclinical Huntington’s disease. J Clin Exp Neuropsychol 24:133–145CrossRefPubMedGoogle Scholar
  37. 37.
    Starr A (1967) A disorder of rapid eye movements in Huntington’s chorea. Brain 90:545–564CrossRefPubMedGoogle Scholar
  38. 38.
    Tsai Tzu-Tung LA, David Zee (1995) Visual attention in Huntington’s disease: the effect of cueing on saccade latencies and manual reaction times. Neuropsychologia 33:1617–1626CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Chrystalina A. Antoniades
    • 1
    • 3
    Email author
  • Zheyu Xu
    • 1
  • Sarah L. Mason
    • 1
  • R. H. S. Carpenter
    • 3
  • Roger A. Barker
    • 1
    • 2
  1. 1.Cambridge Centre for Brain Repair, Department of Clinical NeurosciencesUniversity of CambridgeCambridgeUK
  2. 2.Department of NeurologyAddenbrooke’s HospitalCambridgeUK
  3. 3.Department of Physiology, Development and NeuroscienceUniversity of CambridgeCambridgeUK

Personalised recommendations